According to Medifast's latest financial reports the company's total debt is $22.01 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $22.01 M | -15.5% |
2022-12-31 | $26.05 M | -19.95% |
2021-12-31 | $32.54 M | 191.58% |
2020-12-31 | $11.16 M | -17.94% |
2019-12-31 | $13.6 M | |
2018-12-31 | $N/A | |
2016-12-31 | $N/A | -100% |
2015-12-31 | $0.21 M | -91.08% |
2014-12-31 | $2.45 M | 252.59% |
2013-12-31 | $0.69 M | -83.95% |
2012-12-31 | $4.33 M | -23.6% |
2011-12-31 | $5.67 M | -2.1% |
2010-12-31 | $5.79 M | -7.07% |
2009-12-31 | $6.24 M | -19.32% |
2008-12-31 | $7.73 M | 20.22% |
2007-12-31 | $6.43 M | 21.08% |
2006-12-31 | $5.31 M | 2.75% |
2005-12-31 | $5.17 M | 1.73% |
2004-12-31 | $5.08 M | -5.57% |
2003-12-31 | $5.38 M | 73.87% |
2002-12-31 | $3.09 M | 832.53% |
2001-12-31 | $0.33 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.32 B | 1,383.57% | ๐บ๐ธ USA |
Abeona Therapeutics
ABEO | $5.4 M | -75.47% | ๐บ๐ธ USA |
Bellerophon Therapeutics
BLPH | N/A | N/A | ๐บ๐ธ USA |